February 4, 2026
1 min read

OXB expands BMS partnership to churn out lentiviral vectors for commercial CAR-Ts

OXB, a U.K.-based cell and gene therapy manufacturer, expanded its ongoing partnership with Bristol Myers Squibb to supply lentiviral vectors for the pharma giant’s CAR-T programs.

Leave a Reply

Your email address will not be published.

Previous Story

SVH-713066 2026 Senior Nutrition SRVCS

Next Story

Normal BMI hides nutritional gaps in alcohol use disorder

Previous Story

SVH-713066 2026 Senior Nutrition SRVCS

Next Story

Normal BMI hides nutritional gaps in alcohol use disorder

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop